Donald Notman
Director Financiero/CFO en OCULAR THERAPEUTIX, INC. .
Fortuna: 445 535 $ al 31/05/2024
Cargos activos de Donald Notman
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
OCULAR THERAPEUTIX, INC. | Contacto de Relaciones con Inversores | 25/09/2017 | - |
Director Financiero/CFO | 25/09/2017 | - | |
Comptroller/Controller/Auditor | 25/09/2017 | - |
Historial de carrera de Donald Notman
Antiguos cargos conocidos de Donald Notman.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Director Financiero/CFO | 01/05/2014 | 01/03/2017 |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Corporate Officer/Principal | - | - |
Formación de Donald Notman.
Middlebury College | Undergraduate Degree |
Tuck School of Business at Dartmouth | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 5 |
Canadá | 2 |
Operativa
Director of Finance/CFO | 2 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 3 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
OCULAR THERAPEUTIX, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Health Technology |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Finance |
- Bolsa de valores
- Insiders
- Donald Notman
- Experiencia